Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2006-06-20
2006-06-20
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S150100, C424S151100, C424S156100
Reexamination Certificate
active
07063844
ABSTRACT:
Provided are CD-1 presented antigens, compositions, cells, inhibitors and methods relating to the use of hydrophobic antigen presentation by CD1 molecules, including: methods for detecting the presence of a CD1-presented hydrophobic antigen in a sample; methods for isolating such CD1-presented antigens and isolated antigens; vaccines containing CD1-presented antigens and vaccination methods; methods of blocking CD1 antigen presentation; methods of identifying and/or isolating CD1 blocking agents and the isolated CD1 blocking agents; methods of inducing CD1 expression; and T-cells for use in the methods disclosed herein.
REFERENCES:
patent: 4329452 (1982-05-01), Maruyama
patent: 4394502 (1983-07-01), Maruyama
patent: 4455142 (1984-06-01), Martins et al.
patent: 5296466 (1994-03-01), Kilbourn et al.
patent: 5679347 (1997-10-01), Porcelli et al.
patent: 5853737 (1998-12-01), Modlin et al.
patent: 6238676 (2001-05-01), Porcelli et al.
patent: 0604727 (1994-07-01), None
patent: WO 90/00594 (1990-01-01), None
patent: WO 92/01796 (1992-02-01), None
patent: WO 92/14154 (1992-08-01), None
patent: WO 92/14155 (1992-08-01), None
patent: WO 95/00163 (1995-01-01), None
patent: WO 9612190 (1996-04-01), None
patent: WO 98/39025 (1998-09-01), None
patent: WO 99/12562 (1999-03-01), None
patent: WO 99/15199 (1999-04-01), None
patent: WO 03/092615 (2003-11-01), None
Porcelli et al. Nature 1989 5: 447-450.
Faure et al. Eur. J. Immunol. 1990 20: 703-706.
Porcelli et al. Immunological Reviews 1991 No. 120, pp. 137-181.
Porcelli, S. A. Adv. Immunol. 1995 59: 1-98.
Allison , A.C., et al., “Immunological Adjuvants: Desirable Properties and Side-Effects,” Mol. Immunology, 28:279-284 (1991).
Anthony, L.S.D., et al., “Lipoarabinomannan from Mycobacterium tuberculosis Modulates the Generation of Reactive Nitrogen Intermediates by Gamma Interferon-Activated Macrophages,” FEMS Immunology and Medical Microbiology, 8:299-306 (1994).
Azuma, I. et al., “Chemical Synthesis and Biological Activities of 6,6'-di-O-my-coloyl-β,β- and - α, β- trehalose,” Carbohydrate Résearch, 212:47-53 (1991).
Bartra, J.K., et al., “Effect of Cord Factor, A Toxic Glycolipid from Mycobacterium Tuberculosis, on Mouse Liver Drug Metabolizing Enzymes,” Toxicon, 25(3):345-349 (1987).
Beckman, E.M. et al., “CDlc Restricts Responses of Mycobacteria-Specific T Cells,” The Journal of Immunology, 157:2795-2803 (1996).
Beckman, E.M., et al., “MHC Class I-Like, Class II-Like and CDl Molecules: Distinct Roles in Immunity,” Immunology Today, 167(7);349-352 (1995).
Bekierkunst, A., et al., “Immune Response to Sheep Red Blood Cells in Mice Pretreated with Mycobacterial Fractions,” Infection and Immunity, 4(3):256-263 (1971).
Besra, G.S. et al., “Identification of the Apparent Carrier in Mycolic Acid Synthesis,” Proc. Natl. Acid. Sci. USA, 91:12735-12739 (1994).
Bloom, B.R. et al., “Tuberculosis: Commentary on a Reemergent Killer,” Science, 257:1055-1064 (1992).
Bukowski, J.F., et al., “Vγ2Vδ2 TCR-Dependent Recognition of Non-Peptide Antigens and Daudi Cells Analyzed by TCR Gene Transfer,” The Journal of Immunology, 154:998-1006 (1995).
Calabi, F., et al., “Two Classes of CD1 Genes,” Eur. J. Immunol., 19:285-292 (1989).
Calabi, F., et al., Chapter 8, “CD1: From Structure to Function,” Immungenetics of the Major Histocompatibility Complex, edited by Srivastava, R., et al., (1991).
Cerundolo, V., et al., “Presentation of Viral Antigen Controlled by a Gene in the Major Histocompatibility Complex,”Letters to Nature, 345:449-452 (1990).
Constant, P. et al., “Stimulation of Human γδ T Cells by Nonpeptidic Mycobacterial Ligands,”Science, 264: 267-270 (1994).
Cruaud, P., et al., “Evaluation of a Novel 2,3-Diacyl-Trehalose-2'-Sulphate (SL-IV) Antigen for Case Finding and Diagnosis of Leprosy and Tuberculosis,” Res. Microbiol. 141:679-694 (1990).
D'Erchia, A.M., et al., “The Guinea-Pig Is Not a Rodent,” Nature, 381:597-600 (1996).
Daffe, M. et al., “Novel Type-Specific Lipoligosaccharides from Mycobacterium tuberculosis,” Biochemistry, 30:378-388 (1991).
Dorman S.E., et al., “Adjunctive Corticosteroid Therapy for Patients Whose Treatment for Disseminated Mycobacterium Avium Complex Infection Has Failed,” Clinical Infectious Diseases, 26:682-686 (1998).
Ellner, J.J., et al., “Immunosuppression by Mycobacterial Arabinomannan,” Clin. Exp. Immunol., 35:250-257 (1979).
Giuliani A., et al., “Effect of Firampin on CDlb Expression and Double-Negative T Cell Response Against Mycobacteria-Derived Glycolipid Antigen,” Life Sciences 63(12):985-994 (1998).
Gong J. et al., “Isolation of Mycobacterium-Reacvtive CD1-restricted T Cells from patients with Human Immunodeficiency Virus Infection,” J. Clin. invest. 101:383-389 (1998).
Hacker, G., et al., “Opportunist Mycobacteria Express Ligands that Stimulate Production of Human Vγ9Vδ2 T Lymphocytes,” Infection and Immunity, 60(7):2753-2757 (1992).
Haq, T.A., “Oral Immunization with a Recombinant Bacterial Antigen Produced in Transgenic Plants,” Science, 268:714-716 (1995).
Harding, C.V., et al., “Glycopeptides Bind MHC Molecules and Elicit Specific T Cell Responses,” The Journal of Immunology, 151(5):2419-2425 (1993).
Hochstenbach, F. et al., “Endoplasmic Reticulum Resident Protein of 90 Kilodaltons Associates with the T- and B-Cell Antigen Receptors and Major Histocompatibility Complex Antigens During Their Assembly,” Proc. Natl. Acad. Sci. USA, 89:4734-4738 (1992).
Horowitz, M.A., et al., “Protective Immunity Against Tuberculosis Induced by Vaccination with Major Extracellular Proteins Of Mycobacterium tuerculosis,” Proc. Natl. Acad. Sci. USA, 92:1530-1534 (1995).
Howard, C.J., et al., “6.3 Comparison of CD1 Monoclonal Antibodies on Bovine Cells and Tissues,” Veterinary Immunology and Immunopathy, 39:77-83 (1993).
Hunter, S.W., et al., “The Major Native Proteins of the Leprosy Bacillus,” The Journal of Biological Chemistry, 265(24):14065-14068 (1990).
Ishioka, G.Y., et al., “MHC Interaction and T Cell recognition of Carbohydrafts and Glycopeptides,” The Journal of Immunology, 148(8):2446-2451 (1992).
Kasprzak, A.A., et al., “Location of a Contact Site Between Actin and Myosin in the Three-Dimensional Structure of the Acto-Sl Complex,” Biochemistry, 28:9230-9238 (1989).
Kato, M., “Effect of Anti-Cord factor Antibody on Experimental Tuberculosis in Mice,” Infection and Immunity, 7(1):14-21 (1973).
Kato, M., Site II-Specific Inhibition of Mitochondrial Oxidative Phosphorylation by Trehalose-6,6'-dimycolate (Cord Factor) of Mycobacterium tuberculosis, 140:379-390 (1970).
Krag, S.S., “Breakthroughs and Views— The Importance of Being Dolichol,” Biochemical and Biophysical Research Communications, 243:1-5 (1998).
Leclerc, C. et al., “Nonspecific Immunoprevention of L1210 Leukemia by Cord Factor (6-6' Dimycolate of Trehalose) Administered in a Metabolizable Oil,” Cancer Immunol. Immunother., 1:227-232 (1976).
Lemassu, A., et al., “Revised Structure of a Trehalose-Containg Immunoreactive Glycolipid of Mycobacterium Tuberculosis,” FEMS Microbiology Letters, 78:171-176 (1991).
Lotteau, V., et al., “Intacellular Transport of Class II MHC Molecules Directed by Invariant Chain,” Nature, 348:600-605 (1990).
Masihi, K.N., et al., “Stimulation of Nonspecific Resistance Against Aerogenic Viral and Bacterial Infections by Muramyl Dipeptide Combined with Trehalose Dimycolate,”Biological Properties of Peptidoglycan, pp. 401-406 (1986).
Mehta, P.k., et al., “Immunogenicity of Mannophosphoinositides of Mycobacteria: Effect of Cord Factor (Trehalose-6-6'-Dimycolate),” F
Beckman Evan M.
Brenner Michael B.
Furlong Stephen T.
Porcelli Steven A.
Chan Christina
DiBrino Marianne
The Brigham and Women's Hospital, Inc.
Wolf Greenfield & Sacks P.C.
LandOfFree
Presentation of hydrophobic antigens to T-cells by CD1... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Presentation of hydrophobic antigens to T-cells by CD1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Presentation of hydrophobic antigens to T-cells by CD1... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3646562